Halda

Halda Therapeutics

This biotechnology company develops bifunctional small molecules for the precision treatment of patients with solid tumours, including prostate and breast cancers.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

InduPro

This biotechnology company develops proximity-based protein therapeutics for patients with cancer and autoimmune diseases.

Convert Pharmaceuticals

The company develops hypoxia-activated prodrugs that transform into anti-cancer agents to treat patients with solid tumours.

Galera

This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.

Olema Oncology

This biopharmaceutical company develops targeted therapies, including palazestrant, for women diagnosed with estrogen receptor-positive breast cancer and other solid tumours.